| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNB CALM1 CALM2 CALM3 KIF21A SPTB TRPC6 CEP290 ENC1 WHAMM SPAG9 SPATA32 OPA1 SPTBN4 KCNA2 TTLL11 MYPN STAU2 TRIM63 MACF1 EPS8L3 KIF5B MYO18B PLEKHH2 DYNC1I1 EPB41L2 KLC3 | 4.45e-07 | 1099 | 167 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | titin binding | 4.43e-06 | 14 | 167 | 4 | GO:0031432 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 5.68e-06 | 5 | 167 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.13e-05 | 6 | 167 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 4.65e-05 | 9 | 167 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 6.60e-05 | 10 | 167 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 1.55e-04 | 13 | 167 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | actin binding | FLNB SPTB TRPC6 ENC1 WHAMM SPATA32 SPTBN4 MYPN MACF1 EPS8L3 MYO18B PLEKHH2 EPB41L2 | 2.03e-04 | 479 | 167 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | peptidyl-histidine dioxygenase activity | 2.07e-04 | 3 | 167 | 2 | GO:0036139 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 2.97e-04 | 16 | 167 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.97e-04 | 16 | 167 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 3.58e-04 | 17 | 167 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 4.27e-04 | 18 | 167 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 5.90e-04 | 20 | 167 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 7.03e-04 | 229 | 167 | 8 | GO:0003714 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 7.87e-04 | 22 | 167 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.02e-03 | 6 | 167 | 2 | GO:1905030 | |
| GeneOntologyMolecularFunction | kinesin binding | 1.15e-03 | 55 | 167 | 4 | GO:0019894 | |
| GeneOntologyMolecularFunction | ankyrin repeat binding | 1.42e-03 | 7 | 167 | 2 | GO:0071532 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 5.31e-07 | 3 | 168 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 5.72e-07 | 119 | 168 | 9 | GO:1901796 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.61e-06 | 100 | 168 | 8 | GO:0061337 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 4.08e-06 | 30 | 168 | 5 | GO:0098901 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 5.24e-06 | 5 | 168 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | heart contraction | ZMPSTE24 CALM1 CALM2 DSG2 CALM3 SGCD CHGA PPP1R13L SIRT1 SPTBN4 ACE2 AKAP9 | 6.31e-06 | 298 | 168 | 12 | GO:0060047 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 8.25e-06 | 89 | 168 | 7 | GO:0055117 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | TRIB2 CALM1 CALM2 CALM3 DVL1 SPAG9 ADAR PDCD4 SIRT1 TRIM63 CDK5RAP1 DNAJC3 HSPA4 ENSA LILRB4 | 9.03e-06 | 478 | 168 | 15 | GO:0045936 |
| GeneOntologyBiologicalProcess | heart process | ZMPSTE24 CALM1 CALM2 DSG2 CALM3 SGCD CHGA PPP1R13L SIRT1 SPTBN4 ACE2 AKAP9 | 9.09e-06 | 309 | 168 | 12 | GO:0003015 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 9.48e-06 | 167 | 168 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | TRIB2 CALM1 CALM2 CALM3 DVL1 SPAG9 ADAR PDCD4 SIRT1 TRIM63 CDK5RAP1 DNAJC3 HSPA4 ENSA LILRB4 | 9.49e-06 | 480 | 168 | 15 | GO:0010563 |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.04e-05 | 6 | 168 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.04e-05 | 6 | 168 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | TRIB2 RNF168 ZMPSTE24 RNF19A TRIM26 RNF144A ENC1 DVL1 PSMC1 DDI1 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 DNAJC3 RPL11 TBL1X | 1.06e-05 | 812 | 168 | 20 | GO:0051603 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | TRIB2 CALM1 CALM2 CALM3 DVL1 SPAG9 ADAR PDCD4 SIRT1 CDK5RAP1 DNAJC3 HSPA4 LILRB4 | 1.29e-05 | 375 | 168 | 13 | GO:0001933 |
| GeneOntologyBiologicalProcess | regulation of DNA damage response, signal transduction by p53 class mediator | 1.76e-05 | 40 | 168 | 5 | GO:0043516 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | TRIB2 CALM1 CALM2 CALM3 DVL1 SPAG9 ADAR PDCD4 SIRT1 CDK5RAP1 DNAJC3 HSPA4 ENSA RPL11 LILRB4 | 2.02e-05 | 512 | 168 | 15 | GO:0031400 |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | TRIB2 RNF168 ZMPSTE24 RNF19A TRIM26 RNF144A DVL1 PSMC1 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 RPL11 TBL1X | 2.45e-05 | 651 | 168 | 17 | GO:0019941 |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | IL10 TRIB2 CALM1 NLRP7 CALM2 CALM3 CST9 ENC1 INTS1 DVL1 SPAG9 ADAR PDCD4 SIRT1 CAPRIN2 USP7 CDK5RAP1 DNAJC3 HSPA4 ENSA RPL11 USP47 LILRB4 | 2.60e-05 | 1088 | 168 | 23 | GO:0051248 |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | TRIB2 CALM1 CALM2 CALM3 DVL1 SPAG9 ADAR PDCD4 SIRT1 CDK5RAP1 DNAJC3 HSPA4 LILRB4 | 2.61e-05 | 401 | 168 | 13 | GO:0042326 |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | TRIB2 RNF168 ZMPSTE24 RNF19A TRIM26 RNF144A DVL1 PSMC1 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 RPL11 TBL1X | 2.69e-05 | 656 | 168 | 17 | GO:0043632 |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 2.76e-05 | 191 | 168 | 9 | GO:0072331 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 2.88e-05 | 8 | 168 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 3.50e-05 | 111 | 168 | 7 | GO:0006942 | |
| GeneOntologyBiologicalProcess | protein catabolic process | IL10 TRIB2 RNF168 ZMPSTE24 RNF19A TRIM26 RNF144A ENC1 DVL1 PSMC1 SNX33 DDI1 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 ATM DNAJC3 RPL11 TBL1X | 3.80e-05 | 1115 | 168 | 23 | GO:0030163 |
| GeneOntologyBiologicalProcess | regulation of heart contraction | ZMPSTE24 CALM1 CALM2 DSG2 CALM3 CHGA SIRT1 SPTBN4 ACE2 AKAP9 | 3.89e-05 | 249 | 168 | 10 | GO:0008016 |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 4.30e-05 | 9 | 168 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal protein catabolic process | 6.46e-05 | 213 | 168 | 9 | GO:0061136 | |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | TRIB2 TRIM26 ENC1 DVL1 PSMC1 DDI1 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 RPL11 TBL1X | 6.49e-05 | 567 | 168 | 15 | GO:0010498 |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal protein catabolic process | 6.75e-05 | 123 | 168 | 7 | GO:1901800 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | TRIB2 RNF168 RNF19A TRIM26 RNF144A DVL1 PSMC1 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 RPL11 TBL1X | 7.17e-05 | 640 | 168 | 16 | GO:0006511 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 7.46e-05 | 217 | 168 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | intracellular transport | SCFD2 SMG1 AFTPH ZMPSTE24 WASHC2C CEP290 WHAMM FYCO1 SPAG9 SNX33 ARFIP2 WASHC2A ADAR OPA1 STAR PIKFYVE ZC3H11A BCAP31 BBS7 STAU2 USP7 SERAC1 KIF5B NAGPA HSPA4 DYNC1I1 KLC3 | 7.71e-05 | 1496 | 168 | 27 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of blood circulation | ZMPSTE24 HTR2C CALM1 CALM2 DSG2 CALM3 CHGA SIRT1 SPTBN4 ACE2 AKAP9 | 7.75e-05 | 326 | 168 | 11 | GO:1903522 |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway | 8.26e-05 | 127 | 168 | 7 | GO:2001243 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 8.35e-05 | 11 | 168 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 9.12e-05 | 129 | 168 | 7 | GO:0002027 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 1.11e-04 | 12 | 168 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 1.11e-04 | 12 | 168 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 1.28e-04 | 32 | 168 | 4 | GO:0010800 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1.28e-04 | 32 | 168 | 4 | GO:1902230 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | IL10 TRIB2 RNF19A DVL1 PSMC1 SNX33 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 RPL11 | 1.32e-04 | 407 | 168 | 12 | GO:0042176 |
| GeneOntologyBiologicalProcess | regulation of ubiquitin-dependent protein catabolic process | 1.41e-04 | 185 | 168 | 8 | GO:2000058 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.43e-04 | 13 | 168 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | proteasome-mediated ubiquitin-dependent protein catabolic process | TRIB2 TRIM26 DVL1 PSMC1 SIRT1 CSNK1A1L BBS7 NFE2L2 USP7 TRIM63 RPL11 TBL1X | 1.92e-04 | 424 | 168 | 12 | GO:0043161 |
| GeneOntologyBiologicalProcess | negative regulation of molecular function | IL10 RALGAPA1 TRIB2 CALM1 CALM2 CALM3 CST9 INTS1 TEX14 ADAR PDCD4 SIRT1 ACE2 USP7 CDK5RAP1 DNAJC3 KDM1A RPL11 USP47 LILRB4 | 2.04e-04 | 1005 | 168 | 20 | GO:0044092 |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis involved in protein catabolic process | 2.14e-04 | 148 | 168 | 7 | GO:1903052 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.37e-04 | 253 | 168 | 9 | GO:0099111 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis involved in protein catabolic process | 2.51e-04 | 255 | 168 | 9 | GO:1903050 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 2.75e-04 | 16 | 168 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA damage response, signal transduction by p53 class mediator | 2.75e-04 | 16 | 168 | 3 | GO:0043518 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.75e-04 | 16 | 168 | 3 | GO:1902166 | |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 3.19e-04 | 158 | 168 | 7 | GO:0032006 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 3.32e-04 | 17 | 168 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction by p53 class mediator | 3.40e-04 | 41 | 168 | 4 | GO:1901797 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 3.40e-04 | 41 | 168 | 4 | GO:0051125 | |
| GeneOntologyBiologicalProcess | positive regulation of ubiquitin-dependent protein catabolic process | 3.45e-04 | 114 | 168 | 6 | GO:2000060 | |
| GeneOntologyBiologicalProcess | proteasomal ubiquitin-independent protein catabolic process | 3.91e-04 | 4 | 168 | 2 | GO:0010499 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 3.96e-04 | 18 | 168 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | microtubule-based process | RNF19A KIF21A CEP290 DVL1 CC2D1A FYCO1 OPA1 SIRT1 AKAP9 VANGL1 TTLL11 TTC12 STAU2 MACF1 KIF5B HYDIN DYNC1I1 KLC3 JHY INVS | 3.97e-04 | 1058 | 168 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway | 4.03e-04 | 216 | 168 | 8 | GO:2001242 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis | IL10 TRIB2 NLRP7 CST9 INTS1 DVL1 PSMC1 SNX33 SIRT1 BCAP31 CSNK1A1L BBS7 NFE2L2 USP7 RPL11 USP47 | 4.18e-04 | 748 | 168 | 16 | GO:0030162 |
| GeneOntologyBiologicalProcess | DNA damage response, signal transduction by p53 class mediator | 4.41e-04 | 78 | 168 | 5 | GO:0030330 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 4.47e-04 | 44 | 168 | 4 | GO:1902229 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 4.47e-04 | 44 | 168 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 4.67e-04 | 19 | 168 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | actin filament-based process | FLNB WASHC2C DSG2 SGCD ARHGEF5 SPTB WHAMM ARFIP2 WASHC2A SPTBN4 AKAP9 MYPN STAU2 PCDH15 TTC17 MYO18B PLEKHH2 EPB41L2 | 4.75e-04 | 912 | 168 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 5.14e-04 | 171 | 168 | 7 | GO:0044839 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 5.25e-04 | 81 | 168 | 5 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 5.46e-04 | 20 | 168 | 3 | GO:1902165 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 5.76e-04 | 228 | 168 | 8 | GO:0045732 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 5.76e-04 | 47 | 168 | 4 | GO:0034314 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 6.34e-04 | 21 | 168 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | ZMPSTE24 WASHC2C CALM1 CALM2 SPTB FYCO1 SPTBN4 KIF5B PLEKHH2 | 6.55e-04 | 291 | 168 | 9 | GO:0032984 |
| GeneOntologyBiologicalProcess | TOR signaling | 7.20e-04 | 181 | 168 | 7 | GO:0031929 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | BOC FLNB ZMPSTE24 TRPC6 LAMA1 DVL1 SPART CC2D1A SPAG9 OPA1 SPTBN4 ARHGAP4 CSNK1A1L MYPN STAU2 CAPRIN2 PCDH15 MACF1 KIF5B KDM1A EPB41L2 | 7.26e-04 | 1194 | 168 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.28e-04 | 87 | 168 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 7.29e-04 | 22 | 168 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF21A FYCO1 OPA1 VANGL1 TTC12 STAU2 KIF5B HYDIN DYNC1I1 KLC3 JHY INVS | 7.41e-04 | 493 | 168 | 12 | GO:0007018 |
| GeneOntologyBiologicalProcess | cardiac cell development | 7.50e-04 | 132 | 168 | 6 | GO:0055006 | |
| GeneOntologyBiologicalProcess | DNA repair-dependent chromatin remodeling | 8.34e-04 | 23 | 168 | 3 | GO:0140861 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 8.48e-04 | 52 | 168 | 4 | GO:0010799 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 8.48e-04 | 52 | 168 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | BOC TRPC6 LAMA1 DVL1 SPART CC2D1A SPAG9 OPA1 SPTBN4 ARHGAP4 MYPN STAU2 CAPRIN2 MACF1 KIF5B KDM1A | 8.82e-04 | 802 | 168 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors | 8.93e-04 | 91 | 168 | 5 | GO:0002200 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 8.93e-04 | 91 | 168 | 5 | GO:0140115 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 9.47e-04 | 24 | 168 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | WASHC2C DSG2 ARHGEF5 SPTB WHAMM ARFIP2 WASHC2A SPTBN4 AKAP9 STAU2 PLEKHH2 | 9.56e-04 | 438 | 168 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | plus-end-directed vesicle transport along microtubule | 9.68e-04 | 6 | 168 | 2 | GO:0072383 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | TRIB2 CALM1 CALM2 CALM3 ARHGEF5 MAPKAPK5 ADAR PDCD4 SIRT1 SERINC1 DSTYK CDK5RAP1 ATM DNAJC3 RPL11 LILRB4 | 9.79e-04 | 810 | 168 | 16 | GO:0051338 |
| GeneOntologyBiologicalProcess | regulation of proteasomal ubiquitin-dependent protein catabolic process | 9.82e-04 | 139 | 168 | 6 | GO:0032434 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.02e-03 | 249 | 168 | 8 | GO:0010976 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | BOC TRPC6 LAMA1 DVL1 SPART CC2D1A SPAG9 OPA1 SPTBN4 ARHGAP4 MYPN STAU2 CAPRIN2 MACF1 KIF5B KDM1A | 1.10e-03 | 819 | 168 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.18e-03 | 144 | 168 | 6 | GO:0043244 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 1.19e-03 | 97 | 168 | 5 | GO:0032414 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 1.20e-03 | 317 | 168 | 9 | GO:0090257 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | BOC TRPC6 LAMA1 DVL1 SPART CC2D1A SPAG9 OPA1 SPTBN4 ARHGAP4 MYPN STAU2 CAPRIN2 MACF1 KIF5B KDM1A | 1.20e-03 | 826 | 168 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 1.20e-03 | 26 | 168 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 1.20e-03 | 26 | 168 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | BOC TRPC6 LAMA1 DVL1 SPART CC2D1A OPA1 SPTBN4 ARHGAP4 MYPN STAU2 CAPRIN2 PCDH15 MACF1 KIF5B | 1.22e-03 | 748 | 168 | 15 | GO:0048667 |
| GeneOntologyCellularComponent | microtubule | CALM1 CALM2 CALM3 KIF21A DVL1 RIBC1 WHAMM OPA1 ARHGAP4 TTLL11 STAU2 TRIM63 MACF1 KIF5B DYNC1I1 KLC3 INVS | 1.91e-06 | 533 | 171 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | centrosome | CALM1 CALM2 CALM3 RNF19A CEP290 CC2D1A SPAG9 CHD4 IVL CSNK1A1L AKAP9 RRAGD BBS7 NFE2L2 TTC12 CAPRIN2 CCDC15 KIF5B ATM | 1.87e-05 | 770 | 171 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | spectrin | 4.36e-05 | 9 | 171 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CALM1 CALM2 CALM3 KIF21A DVL1 RIBC1 WHAMM OPA1 SPTBN4 ARHGAP4 CSNK1A1L TTLL11 STAU2 TRIM63 MACF1 KIF5B MYO18B DYNC1I1 KLC3 INVS | 4.85e-05 | 899 | 171 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule organizing center | CALM1 CALM2 CALM3 RNF19A CEP290 CC2D1A SPAG9 CHD4 IVL CSNK1A1L AKAP9 RRAGD BBS7 NFE2L2 TTLL11 TTC12 CAPRIN2 CCDC15 KIF5B ATM | 6.57e-05 | 919 | 171 | 20 | GO:0005815 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.03e-04 | 91 | 171 | 6 | GO:0008076 | |
| GeneOntologyCellularComponent | growth cone | 1.93e-04 | 245 | 171 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | calyx of Held | 2.08e-04 | 36 | 171 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.15e-04 | 104 | 171 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.45e-04 | 253 | 171 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNB CALM1 CALM2 CALM3 KIF21A DVL1 RIBC1 WHAMM OPA1 SPTBN4 ARHGAP4 CSNK1A1L TTLL11 MYPN STAU2 TRIM63 MACF1 KIF5B MYO18B DYNC1I1 KLC3 INVS | 2.57e-04 | 1179 | 171 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | FLNB CALM1 CALM2 CALM3 KIF21A DVL1 RIBC1 WHAMM OPA1 SPTBN4 ARHGAP4 CSNK1A1L TTLL11 MYPN STAU2 TRIM63 MACF1 KIF5B MYO18B DYNC1I1 KLC3 INVS | 2.82e-04 | 1187 | 171 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | axon | BOC CALM1 CALM2 CALM3 KIF21A DVL1 CPLX4 OPA1 SIRT1 SPTBN4 ARHGAP4 KCNA2 MYPN STAU2 KIF5B PUM1 DYNC1I1 HNRNPR | 3.82e-04 | 891 | 171 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | cilium | CALM1 CALM2 CALM3 CFAP36 CEP290 RIBC1 ACE2 CSNK1A1L AKAP9 BBS7 TTLL11 PCDH15 KIF5B CPLANE1 HYDIN KLC3 INVS DRC3 | 4.19e-04 | 898 | 171 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | DNA repair complex | 8.44e-04 | 23 | 171 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | distal axon | BOC CALM1 CALM2 CALM3 DVL1 CPLX4 SIRT1 ARHGAP4 KCNA2 KIF5B HNRNPR | 9.39e-04 | 435 | 171 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.23e-03 | 317 | 171 | 9 | GO:0032838 | |
| MousePheno | abnormal spermatocyte morphology | 1.45e-06 | 84 | 135 | 8 | MP:0006379 | |
| MousePheno | cardiac muscle degeneration | 8.69e-06 | 5 | 135 | 3 | MP:0009416 | |
| Domain | ACTININ_2 | 4.78e-05 | 23 | 167 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.78e-05 | 23 | 167 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.78e-05 | 23 | 167 | 4 | IPR001589 | |
| Domain | ARHGEF5_35 | 7.95e-05 | 2 | 167 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 7.95e-05 | 2 | 167 | 2 | IPR029212 | |
| Domain | DVL-1 | 7.95e-05 | 2 | 167 | 2 | IPR008340 | |
| Domain | FAM21 | 7.95e-05 | 2 | 167 | 2 | IPR027308 | |
| Domain | ATM/Tel1 | 7.95e-05 | 2 | 167 | 2 | IPR015519 | |
| Domain | CAP-ZIP_m | 2.37e-04 | 3 | 167 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 2.37e-04 | 3 | 167 | 2 | IPR029341 | |
| Domain | ARM-type_fold | RALGAPA1 SMG1 HGH1 INTS1 PDCD4 ANKAR TTC12 SERAC1 ATM BZW1 PUM1 | 2.44e-04 | 339 | 167 | 11 | IPR016024 |
| Domain | EF-hand_1 | 4.40e-04 | 152 | 167 | 7 | PF00036 | |
| Domain | Dishevelled | 4.71e-04 | 4 | 167 | 2 | PF02377 | |
| Domain | Spectrin_bsu | 4.71e-04 | 4 | 167 | 2 | IPR016343 | |
| Domain | Dishevelled_fam | 4.71e-04 | 4 | 167 | 2 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 4.71e-04 | 4 | 167 | 2 | IPR003351 | |
| Domain | FATC | 7.81e-04 | 5 | 167 | 2 | PF02260 | |
| Domain | DEP | 9.54e-04 | 22 | 167 | 3 | PF00610 | |
| Domain | DEP | 9.54e-04 | 22 | 167 | 3 | PS50186 | |
| Domain | DEP | 9.54e-04 | 22 | 167 | 3 | SM00049 | |
| Domain | EF_Hand_1_Ca_BS | 1.01e-03 | 175 | 167 | 7 | IPR018247 | |
| Domain | DEP_dom | 1.09e-03 | 23 | 167 | 3 | IPR000591 | |
| Domain | Spectrin | 1.09e-03 | 23 | 167 | 3 | PF00435 | |
| Domain | FAT | 1.16e-03 | 6 | 167 | 2 | PS51189 | |
| Domain | FATC | 1.16e-03 | 6 | 167 | 2 | PS51190 | |
| Domain | FATC_dom | 1.16e-03 | 6 | 167 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.16e-03 | 6 | 167 | 2 | IPR014009 | |
| Domain | FATC | 1.16e-03 | 6 | 167 | 2 | SM01343 | |
| Domain | Cupin_4 | 1.62e-03 | 7 | 167 | 2 | PF08007 | |
| Domain | DIX | 1.62e-03 | 7 | 167 | 2 | PF00778 | |
| Domain | DIX | 1.62e-03 | 7 | 167 | 2 | IPR001158 | |
| Domain | DIX | 1.62e-03 | 7 | 167 | 2 | PS50841 | |
| Domain | DAX | 1.62e-03 | 7 | 167 | 2 | SM00021 | |
| Domain | ig | 1.63e-03 | 190 | 167 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.63e-03 | 190 | 167 | 7 | IPR013151 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 6.40e-06 | 5 | 123 | 3 | MM14493 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 1.27e-05 | 6 | 123 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.27e-05 | 6 | 123 | 3 | MM15662 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 2.21e-05 | 7 | 123 | 3 | MM1357 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 3.85e-05 | 44 | 123 | 5 | M39845 | |
| Pathway | WP_JOUBERT_SYNDROME | 5.18e-05 | 76 | 123 | 6 | M39835 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 5.24e-05 | 9 | 123 | 3 | M3412 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 7.44e-05 | 10 | 123 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 7.44e-05 | 10 | 123 | 3 | M47954 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.29e-05 | 27 | 123 | 4 | MM15053 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.02e-04 | 11 | 123 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.02e-04 | 11 | 123 | 3 | M47958 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 1.35e-04 | 12 | 123 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.35e-04 | 12 | 123 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 1.35e-04 | 12 | 123 | 3 | M47956 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RALGAPA1 CALM1 CALM2 DSG2 CALM3 ARHGEF5 DVL1 WHAMM ARHGAP4 ARHGAP5 BCAP31 VANGL1 KIF5B ARHGAP45 DYNC1I1 KLC3 | 1.63e-04 | 649 | 123 | 16 | MM15690 |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.74e-04 | 13 | 123 | 3 | MM15078 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.20e-04 | 14 | 123 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.20e-04 | 14 | 123 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.20e-04 | 14 | 123 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.20e-04 | 14 | 123 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.20e-04 | 14 | 123 | 3 | MM15391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.73e-04 | 15 | 123 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.73e-04 | 15 | 123 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 2.73e-04 | 15 | 123 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 2.73e-04 | 15 | 123 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 2.73e-04 | 15 | 123 | 3 | MM14795 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.34e-04 | 16 | 123 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 3.34e-04 | 16 | 123 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 3.34e-04 | 16 | 123 | 3 | M47449 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 4.03e-04 | 17 | 123 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 4.03e-04 | 17 | 123 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 4.03e-04 | 17 | 123 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 4.03e-04 | 17 | 123 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 4.03e-04 | 17 | 123 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 4.03e-04 | 17 | 123 | 3 | M2349 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 4.67e-04 | 261 | 123 | 9 | M42565 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 4.81e-04 | 18 | 123 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.81e-04 | 18 | 123 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 4.81e-04 | 18 | 123 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 4.81e-04 | 18 | 123 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 4.81e-04 | 18 | 123 | 3 | M3430 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 5.25e-04 | 76 | 123 | 5 | M9052 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 5.67e-04 | 19 | 123 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.67e-04 | 19 | 123 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 5.67e-04 | 19 | 123 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 6.63e-04 | 20 | 123 | 3 | MM1445 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 6.63e-04 | 20 | 123 | 3 | MM1476 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 7.69e-04 | 21 | 123 | 3 | M11650 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 7.69e-04 | 21 | 123 | 3 | M1001 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 7.69e-04 | 21 | 123 | 3 | M47542 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 8.63e-04 | 49 | 123 | 4 | MM1442 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 8.84e-04 | 22 | 123 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 8.84e-04 | 22 | 123 | 3 | MM15519 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.01e-03 | 23 | 123 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.01e-03 | 23 | 123 | 3 | MM15222 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.02e-03 | 88 | 123 | 5 | M16004 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.15e-03 | 24 | 123 | 3 | M47509 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.30e-03 | 25 | 123 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.30e-03 | 25 | 123 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 1.30e-03 | 25 | 123 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.30e-03 | 25 | 123 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.30e-03 | 25 | 123 | 3 | M47511 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 1.46e-03 | 26 | 123 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 1.46e-03 | 26 | 123 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.46e-03 | 26 | 123 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.46e-03 | 26 | 123 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 1.46e-03 | 26 | 123 | 3 | MM1431 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RALGAPA1 CALM1 DSG2 ARHGEF5 DVL1 WHAMM ARHGAP4 ARHGAP5 BCAP31 VANGL1 KIF5B ARHGAP45 KDM1A DYNC1I1 KLC3 | 1.50e-03 | 720 | 123 | 15 | M41838 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.52e-03 | 142 | 123 | 6 | MM15576 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 1.63e-03 | 27 | 123 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 1.63e-03 | 27 | 123 | 3 | M7739 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.73e-03 | 99 | 123 | 5 | MM14910 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.73e-03 | 59 | 123 | 4 | M261 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.81e-03 | 28 | 123 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 1.81e-03 | 28 | 123 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.81e-03 | 28 | 123 | 3 | M47508 | |
| Pathway | KEGG_MELANOGENESIS | 1.89e-03 | 101 | 123 | 5 | M7761 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.94e-03 | 149 | 123 | 6 | M41805 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.01e-03 | 29 | 123 | 3 | MM1356 | |
| Pathway | REACTOME_MYOGENESIS | 2.01e-03 | 29 | 123 | 3 | M853 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.01e-03 | 29 | 123 | 3 | M13494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.01e-03 | 29 | 123 | 3 | MM15219 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 2.01e-03 | 29 | 123 | 3 | MM1495 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 2.04e-03 | 8 | 123 | 2 | M42528 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.06e-03 | 103 | 123 | 5 | MM15196 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 2.22e-03 | 30 | 123 | 3 | M9664 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.22e-03 | 30 | 123 | 3 | MM15170 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 2.22e-03 | 326 | 123 | 9 | M39379 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 2.44e-03 | 31 | 123 | 3 | MM14896 | |
| Pathway | KEGG_GLIOMA | 2.48e-03 | 65 | 123 | 4 | M1835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.61e-03 | 9 | 123 | 2 | M47699 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.67e-03 | 32 | 123 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.67e-03 | 32 | 123 | 3 | MM15143 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.92e-03 | 33 | 123 | 3 | M9494 | |
| Pathway | WP_CAMKK2_PATHWAY | 2.92e-03 | 33 | 123 | 3 | M40047 | |
| Pathway | WP_MELANOMA | 2.92e-03 | 68 | 123 | 4 | M39811 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 3.18e-03 | 34 | 123 | 3 | M10287 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 3.18e-03 | 34 | 123 | 3 | MM15985 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 3.18e-03 | 34 | 123 | 3 | MM1399 | |
| Pubmed | 6.19e-10 | 4 | 175 | 4 | 9096366 | ||
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 3.08e-09 | 5 | 175 | 4 | 23446637 | |
| Pubmed | SCFD2 RALGAPA1 FKBP10 AFTPH DSG2 ATAD5 NUCB1 SPART CC2D1A WASHC2A SIRT1 BCAP31 PNPLA6 AKAP9 BBS7 VANGL1 N4BP2 STAU2 CDK5RAP1 MACF1 TTC17 ATM SUCO DNAJC3 HSPA4 ENSA EPB41L2 | 7.82e-09 | 1487 | 175 | 27 | 33957083 | |
| Pubmed | 9.22e-09 | 6 | 175 | 4 | 18694559 | ||
| Pubmed | Conserved motif of CDK5RAP2 mediates its localization to centrosomes and the Golgi complex. | 9.22e-09 | 6 | 175 | 4 | 20466722 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AFTPH WASHC2C CALM1 DSG2 ATAD5 SPART CC2D1A SPAG9 CHD4 ADAR PDCD4 ZC3H11A STAU2 USP7 ZNF638 MACF1 KIF5B HSPA4 ENSA EPB41L2 RPL11 | 1.18e-08 | 934 | 175 | 21 | 33916271 |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 1.27e-08 | 16 | 175 | 5 | 16403292 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 1.79e-08 | 17 | 175 | 5 | 20878400 | |
| Pubmed | 1.79e-08 | 17 | 175 | 5 | 19450876 | ||
| Pubmed | 1.79e-08 | 17 | 175 | 5 | 19761533 | ||
| Pubmed | 1.79e-08 | 17 | 175 | 5 | 20650299 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 1.79e-08 | 17 | 175 | 5 | 19218127 | |
| Pubmed | 2.14e-08 | 35 | 175 | 6 | 19683555 | ||
| Pubmed | 2.47e-08 | 18 | 175 | 5 | 20200544 | ||
| Pubmed | BOC SMG1 MYF6 FLNB RBBP5 SGCD SPTB SPART CHD4 AKAP9 MYPN TRIM63 MACF1 MYO18B HNRNPR | 3.87e-08 | 497 | 175 | 15 | 23414517 | |
| Pubmed | 4.27e-08 | 8 | 175 | 4 | 21602787 | ||
| Pubmed | CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. | 4.27e-08 | 8 | 175 | 4 | 16760425 | |
| Pubmed | 4.44e-08 | 20 | 175 | 5 | 20426625 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 4.44e-08 | 20 | 175 | 5 | 20193031 | |
| Pubmed | FLNB AFTPH WASHC2C CC2D1A PPP1R13L ADAR PDCD4 SIRT1 ZC3H11A MYPN STAU2 ZNF638 BZW1 EPB41L2 USP47 | 4.53e-08 | 503 | 175 | 15 | 16964243 | |
| Pubmed | 7.48e-08 | 22 | 175 | 5 | 20492596 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 29932249 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.25e-07 | 3 | 175 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.25e-07 | 3 | 175 | 3 | 9923700 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.25e-07 | 3 | 175 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.25e-07 | 3 | 175 | 3 | 8573130 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 10899953 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 8862395 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 14978283 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 33191766 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 19651602 | ||
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.25e-07 | 3 | 175 | 3 | 3384819 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 21799007 | ||
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.25e-07 | 3 | 175 | 3 | 18786401 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 11072229 | ||
| Pubmed | Promoter variants of KIR2DL5 add to diversity and may impact gene expression. | 1.25e-07 | 3 | 175 | 3 | 18461314 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 15063758 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.25e-07 | 3 | 175 | 3 | 17582331 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 18370588 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.25e-07 | 3 | 175 | 3 | 9278050 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.25e-07 | 3 | 175 | 3 | 11847276 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 10416864 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 7828884 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.25e-07 | 3 | 175 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.25e-07 | 3 | 175 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.25e-07 | 3 | 175 | 3 | 8631777 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 18553937 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.25e-07 | 3 | 175 | 3 | 11054265 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 18940602 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 25268113 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 26969752 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.25e-07 | 3 | 175 | 3 | 11807546 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 8312049 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 37380439 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.25e-07 | 3 | 175 | 3 | 11710561 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.25e-07 | 3 | 175 | 3 | 9362478 | |
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.25e-07 | 3 | 175 | 3 | 20956522 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 16229872 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 8226798 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 9658102 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | FLNB WASHC2C CALM1 PSMC1 CHD4 PDCD4 ZC3H11A USP7 ZNF638 KIF5B BZW1 HNRNPR | 1.37e-07 | 332 | 175 | 12 | 32786267 |
| Pubmed | 1.99e-07 | 11 | 175 | 4 | 10757985 | ||
| Pubmed | 2.97e-07 | 12 | 175 | 4 | 20137308 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 3.28e-07 | 29 | 175 | 5 | 20082482 | |
| Pubmed | 4.27e-07 | 13 | 175 | 4 | 19120281 | ||
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 4.99e-07 | 4 | 175 | 3 | 7607248 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 27516456 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 30842726 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 16299511 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 25437912 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 10692436 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 16478480 | ||
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 4.99e-07 | 4 | 175 | 3 | 14960328 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 22405011 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 20953164 | ||
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 4.99e-07 | 4 | 175 | 3 | 16338416 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 4.99e-07 | 4 | 175 | 3 | 20103772 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 12577052 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 4.99e-07 | 4 | 175 | 3 | 22067155 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 25441029 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 16505387 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 4.99e-07 | 4 | 175 | 3 | 23040497 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 4.99e-07 | 4 | 175 | 3 | 15499021 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 4.99e-07 | 4 | 175 | 3 | 16127172 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 20226167 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 4.99e-07 | 4 | 175 | 3 | 25519244 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 4.99e-07 | 4 | 175 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 4.99e-07 | 4 | 175 | 3 | 11807557 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 11286509 | ||
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 4.99e-07 | 4 | 175 | 3 | 14594800 | |
| Interaction | SUMO2 interactions | FLNB RNF168 WASHC2C CALM1 TRIM26 PSMC1 CHD4 PDCD4 SIRT1 ACE2 ZC3H11A NFE2L2 USP7 ZNF638 TRIM63 KIF5B BZW1 KDM1A HNRNPR | 7.63e-07 | 591 | 172 | 19 | int:SUMO2 |
| Interaction | ZNF280A interactions | 8.61e-06 | 16 | 172 | 4 | int:ZNF280A | |
| Interaction | CCDC8 interactions | FLNB CALM1 CALM2 DSG2 CALM3 CEP290 INTS1 PSMC1 CHD4 BBS7 VANGL1 STAU2 MACF1 PUM1 HSPA4 EPB41L2 RPL11 HNRNPR | 1.35e-05 | 656 | 172 | 18 | int:CCDC8 |
| Interaction | SPATA17 interactions | 2.09e-05 | 7 | 172 | 3 | int:SPATA17 | |
| Interaction | KDM6B interactions | 3.09e-05 | 104 | 172 | 7 | int:KDM6B | |
| Interaction | KCNN1 interactions | 3.32e-05 | 8 | 172 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 3.32e-05 | 8 | 172 | 3 | int:ARPP21 | |
| Interaction | KCNA3 interactions | RALGAPA1 FLNB ZMPSTE24 DSG2 LAMA1 PSMC1 SPART CC2D1A FYCO1 OPA1 BCAP31 KCNA2 VANGL1 CAPRIN2 MACF1 KIF5B BZW1 HSPA4 EPB41L2 RPL11 | 5.62e-05 | 871 | 172 | 20 | int:KCNA3 |
| Interaction | IQCG interactions | 7.02e-05 | 10 | 172 | 3 | int:IQCG | |
| Interaction | CALM2 interactions | 7.14e-05 | 206 | 172 | 9 | int:CALM2 | |
| Interaction | SPSB2 interactions | 7.30e-05 | 51 | 172 | 5 | int:SPSB2 | |
| Interaction | PPP6R3 interactions | 7.74e-05 | 258 | 172 | 10 | int:PPP6R3 | |
| Interaction | NFE2 interactions | 8.30e-05 | 84 | 172 | 6 | int:NFE2 | |
| Interaction | IQCB1 interactions | FLNB CALM1 CALM2 CALM3 CEP290 NUCB1 FYCO1 SIRT1 KCNA2 ANKAR HSPA4 INVS | 8.35e-05 | 370 | 172 | 12 | int:IQCB1 |
| Interaction | CCP110 interactions | 9.18e-05 | 166 | 172 | 8 | int:CCP110 | |
| Interaction | NAA40 interactions | AFTPH WASHC2C CALM1 DSG2 ATAD5 SPART CC2D1A SPAG9 CHD4 ADAR PDCD4 ZC3H11A STAU2 USP7 ZNF638 MACF1 KIF5B HSPA4 ENSA EPB41L2 RPL11 | 9.42e-05 | 978 | 172 | 21 | int:NAA40 |
| Interaction | PPEF2 interactions | 1.03e-04 | 29 | 172 | 4 | int:PPEF2 | |
| Interaction | ANKS6 interactions | 1.15e-04 | 56 | 172 | 5 | int:ANKS6 | |
| Interaction | ESCO1 interactions | 1.18e-04 | 30 | 172 | 4 | int:ESCO1 | |
| Interaction | RNF145 interactions | 1.18e-04 | 30 | 172 | 4 | int:RNF145 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 7.32e-08 | 18 | 114 | 5 | 620 | |
| GeneFamily | EF-hand domain containing | 7.47e-05 | 219 | 114 | 8 | 863 | |
| GeneFamily | WASH complex | 5.81e-04 | 6 | 114 | 2 | 1331 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.11e-04 | 7 | 114 | 2 | 1113 | |
| GeneFamily | Transcription elongation factor A like family | 1.38e-03 | 9 | 114 | 2 | 1216 | |
| Coexpression | IBRAHIM_NRF2_UP | AFTPH WASHC2C KIF21A CEP290 PSMC1 SPART WASHC2A OPA1 BCAP31 RRAGD NFE2L2 STAU2 TTC17 KIF5B SUCO DNAJC3 HSPA4 | 1.01e-07 | 533 | 173 | 17 | M42510 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 TCEAL3 CFAP36 CEP290 OPA1 ARHGAP5 CAPRIN2 ZNF638 TRIM63 GOLIM4 KIF5B ATM CPLANE1 SUCO DNAJC3 DYNC1I1 USP47 | 1.80e-06 | 656 | 173 | 17 | M18979 |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | TRIB2 CALM1 CALM2 PSMC1 CHGA ADAR SERINC1 STAU2 KCNK1 PUM1 ENSA KDM1A DYNC1I1 HNRNPR | 1.75e-05 | 547 | 173 | 14 | M2110 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | RALGAPA1 SMG1 RNF168 ENC1 CHD4 AKAP9 SERINC1 USP7 SRPK3 CPLANE1 SUCO DNAJC3 TBL1X | 2.62e-06 | 339 | 165 | 13 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 RNF168 CEP290 MAPKAPK5 OPA1 AKAP9 NFE2L2 MACF1 CPLANE1 HSPA4 ENSA | 1.80e-05 | 291 | 165 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.29e-05 | 85 | 165 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-09 | 200 | 171 | 10 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.46e-08 | 200 | 171 | 9 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.46e-08 | 200 | 171 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.61e-07 | 183 | 171 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 186 | 171 | 8 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 186 | 171 | 8 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 7.45e-07 | 190 | 171 | 8 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-07 | 194 | 171 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.42e-07 | 196 | 171 | 8 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-06 | 200 | 171 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.10e-06 | 200 | 171 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.10e-06 | 200 | 171 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.37e-06 | 143 | 171 | 7 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.50e-06 | 171 | 171 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.53e-06 | 181 | 171 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 7.02e-06 | 183 | 171 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.27e-06 | 184 | 171 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.39e-06 | 121 | 171 | 6 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-06 | 185 | 171 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-06 | 188 | 171 | 7 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-06 | 188 | 171 | 7 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-06 | 188 | 171 | 7 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-06 | 189 | 171 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 8.66e-06 | 189 | 171 | 7 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-06 | 189 | 171 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-06 | 189 | 171 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 8.66e-06 | 189 | 171 | 7 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-06 | 189 | 171 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 8.66e-06 | 189 | 171 | 7 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 171 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 192 | 171 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 9.59e-06 | 192 | 171 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 192 | 171 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.92e-06 | 193 | 171 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 195 | 171 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 195 | 171 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.13e-05 | 197 | 171 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-05 | 197 | 171 | 7 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.13e-05 | 197 | 171 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.13e-05 | 197 | 171 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-05 | 198 | 171 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 198 | 171 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.21e-05 | 199 | 171 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 200 | 171 | 7 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 200 | 171 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | PBMC-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.52e-05 | 81 | 171 | 5 | 6d1e524f000b71c935359afc801a1d31f218fec8 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.99e-05 | 144 | 171 | 6 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.42e-05 | 149 | 171 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.02e-05 | 155 | 171 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.13e-05 | 156 | 171 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-05 | 159 | 171 | 6 | ba82d1f55dd77c4b2183981b76cab1480fba75ad | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 160 | 171 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 160 | 171 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.87e-05 | 162 | 171 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.58e-05 | 167 | 171 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 168 | 171 | 6 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 168 | 171 | 6 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.23e-05 | 171 | 171 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.73e-05 | 179 | 171 | 6 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.16e-05 | 181 | 171 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 7.23e-05 | 112 | 171 | 5 | 9c3fb470708e76a8f8a3cb9aa17ab130c60fee11 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 182 | 171 | 6 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-05 | 182 | 171 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.38e-05 | 182 | 171 | 6 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 182 | 171 | 6 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 182 | 171 | 6 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.38e-05 | 182 | 171 | 6 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 183 | 171 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.61e-05 | 183 | 171 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 187 | 171 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 188 | 171 | 6 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 188 | 171 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 188 | 171 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.82e-05 | 188 | 171 | 6 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 188 | 171 | 6 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 9.09e-05 | 189 | 171 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.35e-05 | 190 | 171 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-05 | 190 | 171 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 190 | 171 | 6 | db19c72d8c8053262b535068c5a9d4d696989cb1 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.63e-05 | 191 | 171 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 9.63e-05 | 191 | 171 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.91e-05 | 192 | 171 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 192 | 171 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.91e-05 | 192 | 171 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 192 | 171 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 192 | 171 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 193 | 171 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-04 | 193 | 171 | 6 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-04 | 193 | 171 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 1.02e-04 | 193 | 171 | 6 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.02e-04 | 193 | 171 | 6 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 194 | 171 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.74e-06 | 50 | 101 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 67. | 5.19e-05 | 227 | 101 | 10 | MODULE_67 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.11e-05 | 49 | 101 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | 4-hydroxyphenylglycol | 1.11e-07 | 7 | 173 | 4 | CID003081980 | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | RALGAPA1 RBBP5 ATAD5 ENC1 SPAG9 CHD4 GOLIM4 ATM MMP16 DNAJC3 TBL1X | 2.26e-07 | 189 | 173 | 11 | 4304_DN |
| Drug | NSC366363 | 4.31e-07 | 3 | 173 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 4.31e-07 | 3 | 173 | 3 | CID004630710 | |
| Drug | tatsiensine | 4.31e-07 | 3 | 173 | 3 | CID000163526 | |
| Drug | delcosine | 4.31e-07 | 3 | 173 | 3 | CID000120726 | |
| Drug | Ci988 | 1.69e-06 | 27 | 173 | 5 | CID000108186 | |
| Drug | Nsc642900 | 1.72e-06 | 4 | 173 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 1.72e-06 | 4 | 173 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 1.72e-06 | 4 | 173 | 3 | CID006439702 | |
| Drug | cloxacepride | 1.72e-06 | 4 | 173 | 3 | CID000068859 | |
| Drug | chloraniformethan | 1.72e-06 | 4 | 173 | 3 | CID000030331 | |
| Drug | Ti 233 | 1.72e-06 | 4 | 173 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 1.72e-06 | 4 | 173 | 3 | CID000080867 | |
| Drug | herbarumin III | 1.72e-06 | 4 | 173 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 1.72e-06 | 4 | 173 | 3 | CID000070583 | |
| Drug | KS-504e | 1.72e-06 | 4 | 173 | 3 | CID000129559 | |
| Drug | KS-504d | 1.72e-06 | 4 | 173 | 3 | CID000129557 | |
| Drug | Archanagelicine | 1.72e-06 | 4 | 173 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 1.72e-06 | 4 | 173 | 3 | CID000127194 | |
| Drug | Roylin | 1.72e-06 | 4 | 173 | 3 | CID000099924 | |
| Drug | KS-502 | 1.72e-06 | 4 | 173 | 3 | CID000129242 | |
| Drug | KS-501 | 1.72e-06 | 4 | 173 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 1.72e-06 | 4 | 173 | 3 | CID000637889 | |
| Drug | PS-990 | 1.72e-06 | 4 | 173 | 3 | CID000157810 | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | RALGAPA1 RNF19A RBBP5 CEP290 ENC1 SPAG9 CHD4 ATM MMP16 TBL1X | 2.12e-06 | 191 | 173 | 10 | 4283_DN |
| Drug | SC-52458 | 2.18e-06 | 13 | 173 | 4 | CID000132706 | |
| Drug | A71623 | 2.18e-06 | 13 | 173 | 4 | CID000121964 | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | RALGAPA1 RBBP5 CEP290 ENC1 SPAG9 CHD4 GOLIM4 ATM DNAJC3 TBL1X | 2.44e-06 | 194 | 173 | 10 | 4312_DN |
| Drug | jujubogenin | 4.26e-06 | 5 | 173 | 3 | CID005318721 | |
| Drug | D 890 | 4.26e-06 | 5 | 173 | 3 | CID000134083 | |
| Drug | NSC-36360 | 4.26e-06 | 5 | 173 | 3 | CID000133340 | |
| Drug | alpha-CAO | 4.26e-06 | 5 | 173 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 4.26e-06 | 5 | 173 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 4.26e-06 | 5 | 173 | 3 | CID000021396 | |
| Drug | Y-acid | 4.26e-06 | 5 | 173 | 3 | CID000007022 | |
| Drug | C16AA | 4.26e-06 | 5 | 173 | 3 | CID000488017 | |
| Drug | auranthine | 4.26e-06 | 5 | 173 | 3 | CID000130919 | |
| Drug | Ant-ATP | 4.26e-06 | 5 | 173 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 4.26e-06 | 5 | 173 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 4.26e-06 | 5 | 173 | 3 | CID005748474 | |
| Drug | Ac-dvda | 4.26e-06 | 5 | 173 | 3 | CID000146768 | |
| Drug | VUF 4576 | 4.26e-06 | 5 | 173 | 3 | CID000132784 | |
| Drug | AC1NSV6X | 8.48e-06 | 6 | 173 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 8.48e-06 | 6 | 173 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 8.48e-06 | 6 | 173 | 3 | CID000020218 | |
| Drug | benziodarone | 8.48e-06 | 6 | 173 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 8.48e-06 | 6 | 173 | 3 | CID000633347 | |
| Drug | CI-922 | 8.48e-06 | 6 | 173 | 3 | CID000146938 | |
| Drug | caged PE | 8.48e-06 | 6 | 173 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 8.48e-06 | 6 | 173 | 3 | CID000145934 | |
| Drug | NAADP | 1.12e-05 | 39 | 173 | 5 | CID000123952 | |
| Drug | 1-(4-pyridyl)ethanol | 1.48e-05 | 7 | 173 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 1.48e-05 | 7 | 173 | 3 | CID000196983 | |
| Drug | chloronitromethane | 1.48e-05 | 7 | 173 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 1.48e-05 | 7 | 173 | 3 | CID000159622 | |
| Drug | DyCl3 | 1.48e-05 | 7 | 173 | 3 | CID000066207 | |
| Drug | DAPpNP | 1.48e-05 | 7 | 173 | 3 | CID005492375 | |
| Drug | T 7188 | 1.48e-05 | 7 | 173 | 3 | CID000003311 | |
| Drug | MS-857 | 1.48e-05 | 7 | 173 | 3 | CID000129517 | |
| Drug | SQ 65442 | 1.48e-05 | 7 | 173 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 1.48e-05 | 7 | 173 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.48e-05 | 7 | 173 | 3 | CID000188375 | |
| Drug | TZC-5665 | 1.48e-05 | 7 | 173 | 3 | CID006449836 | |
| Drug | KHL-8430 | 1.48e-05 | 7 | 173 | 3 | CID000195711 | |
| Drug | CPU57 | 1.48e-05 | 7 | 173 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 1.48e-05 | 7 | 173 | 3 | CID000132879 | |
| Drug | asocainol | 1.48e-05 | 7 | 173 | 3 | CID000071161 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.62e-05 | 191 | 173 | 9 | 6020_DN | |
| Drug | NSC 523214 | 1.72e-05 | 147 | 173 | 8 | CID000004752 | |
| Drug | proxyl nitroxide | 2.35e-05 | 8 | 173 | 3 | CID000076702 | |
| Drug | niludipine | 2.35e-05 | 8 | 173 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 2.35e-05 | 8 | 173 | 3 | CID000065839 | |
| Drug | HT-74 | 2.35e-05 | 8 | 173 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 2.35e-05 | 8 | 173 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 2.35e-05 | 8 | 173 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 2.35e-05 | 8 | 173 | 3 | CID000467415 | |
| Drug | KS-504a | 2.35e-05 | 8 | 173 | 3 | CID000129577 | |
| Drug | NSP-805 | 2.35e-05 | 8 | 173 | 3 | CID000130349 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 3.14e-05 | 48 | 173 | 5 | CID000092266 | |
| Drug | w66 | 3.50e-05 | 9 | 173 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 3.50e-05 | 9 | 173 | 3 | CID000159916 | |
| Drug | adamantanone | 3.50e-05 | 9 | 173 | 3 | CID000064151 | |
| Drug | picumast | 3.50e-05 | 9 | 173 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 3.50e-05 | 9 | 173 | 3 | CID000440017 | |
| Drug | KS-505a | 3.50e-05 | 9 | 173 | 3 | CID003081782 | |
| Drug | hydroxamates | 3.60e-05 | 25 | 173 | 4 | CID000033630 | |
| Drug | dibenamine | 4.22e-05 | 26 | 173 | 4 | CID000005820 | |
| Drug | Kr I | 4.97e-05 | 10 | 173 | 3 | CID005288675 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 4.97e-05 | 10 | 173 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 4.97e-05 | 10 | 173 | 3 | CID000062875 | |
| Drug | AC1L8MM4 | 4.97e-05 | 10 | 173 | 3 | CID000429016 | |
| Drug | indolidan | 6.80e-05 | 11 | 173 | 3 | CID005284402 | |
| Drug | 4-iodotamoxifen | 6.80e-05 | 11 | 173 | 3 | CID003037006 | |
| Drug | alpha-amyrin linoleate | 6.80e-05 | 11 | 173 | 3 | CID005318324 | |
| Drug | IQ-3 | 6.80e-05 | 11 | 173 | 3 | CID000028212 | |
| Drug | AC1Q5XN5 | 6.80e-05 | 11 | 173 | 3 | CID000190946 | |
| Drug | AC1L2NX7 | 6.80e-05 | 11 | 173 | 3 | CID000125056 | |
| Drug | Ins(1,3)P2 | 6.80e-05 | 11 | 173 | 3 | CID000128419 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 6.80e-05 | 11 | 173 | 3 | CID003035524 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.04e-05 | 10 | 166 | 3 | C1631597 | |
| Disease | Disorder of eye | 2.84e-05 | 212 | 166 | 8 | C0015397 | |
| Disease | Inherited neuropathies | 7.54e-05 | 40 | 166 | 4 | C0598589 | |
| Disease | Romano-Ward Syndrome | 9.28e-05 | 16 | 166 | 3 | C0035828 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.87e-04 | 4 | 166 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | DiGeorge syndrome (is_implicated_in) | 3.11e-04 | 5 | 166 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | airway responsiveness measurement | 3.24e-04 | 24 | 166 | 3 | EFO_0006897 | |
| Disease | Ciliopathies | 4.03e-04 | 110 | 166 | 5 | C4277690 | |
| Disease | pericardial adipose tissue measurement, body weight, body height | 4.65e-04 | 6 | 166 | 2 | EFO_0004338, EFO_0004339, EFO_0007890 | |
| Disease | Hyperplasia | 5.17e-04 | 28 | 166 | 3 | C0020507 | |
| Disease | Phencyclidine-Related Disorders | 6.49e-04 | 7 | 166 | 2 | C0236742 | |
| Disease | visceral leishmaniasis (is_marker_for) | 6.49e-04 | 7 | 166 | 2 | DOID:9146 (is_marker_for) | |
| Disease | Phencyclidine Abuse | 6.49e-04 | 7 | 166 | 2 | C0031391 | |
| Disease | metastasis measurement, disease progression measurement | 9.20e-04 | 34 | 166 | 3 | EFO_0007675, EFO_0008336 | |
| Disease | Global developmental delay | 9.55e-04 | 133 | 166 | 5 | C0557874 | |
| Disease | Intellectual Disability | 1.01e-03 | 447 | 166 | 9 | C3714756 | |
| Disease | Experimental Autoimmune Encephalomyelitis | 1.10e-03 | 9 | 166 | 2 | C0014072 | |
| Disease | afamin measurement | 1.10e-03 | 9 | 166 | 2 | EFO_0008015 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.18e-03 | 37 | 166 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Cannabis Abuse | 1.37e-03 | 10 | 166 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.37e-03 | 10 | 166 | 2 | C0236735 | |
| Disease | thiamine measurement | 1.37e-03 | 10 | 166 | 2 | EFO_0010540 | |
| Disease | Hashish Abuse | 1.37e-03 | 10 | 166 | 2 | C0018614 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.40e-03 | 145 | 166 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | ciliopathy (implicated_via_orthology) | 1.48e-03 | 40 | 166 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:2 measurement | 1.67e-03 | 11 | 166 | 2 | EFO_0010429 | |
| Disease | liver benign neoplasm (biomarker_via_orthology) | 1.67e-03 | 11 | 166 | 2 | DOID:916 (biomarker_via_orthology) | |
| Disease | liver cirrhosis (is_implicated_in) | 1.83e-03 | 43 | 166 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | Non-Small Cell Lung Carcinoma | 1.93e-03 | 156 | 166 | 5 | C0007131 | |
| Disease | Familial dilated cardiomyopathy | 1.96e-03 | 44 | 166 | 3 | C0340427 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 2.00e-03 | 12 | 166 | 2 | C0403553 | |
| Disease | killer cell immunoglobulin-like receptor 2DL4 measurement | 2.00e-03 | 12 | 166 | 2 | EFO_0008197 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 2.09e-03 | 45 | 166 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.16e-03 | 160 | 166 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | IL10 BOC FLNB INHBE ADAR PDCD4 SIRT1 ZC3H11A AKAP9 N4BP2 GOLIM4 MACF1 ATM HNRNPR | 3.10e-03 | 1074 | 166 | 14 | C0006142 |
| Disease | Muscle hypotonia | 4.05e-03 | 17 | 166 | 2 | C0026827 | |
| Disease | Cannabis Dependence | 4.05e-03 | 17 | 166 | 2 | C0006870 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.05e-03 | 17 | 166 | 2 | C2936862 | |
| Disease | Endometrial Neoplasms | 4.30e-03 | 58 | 166 | 3 | C0014170 | |
| Disease | Polydactyly | 4.37e-03 | 117 | 166 | 4 | C0152427 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 4.54e-03 | 18 | 166 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Hypertrophy | 4.54e-03 | 18 | 166 | 2 | C0020564 | |
| Disease | Bardet-Biedl syndrome | 4.54e-03 | 18 | 166 | 2 | cv:C0752166 | |
| Disease | hypertension (is_implicated_in) | 4.93e-03 | 121 | 166 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | response to methotrexate, neurotoxicity | 5.05e-03 | 19 | 166 | 2 | EFO_0011057, GO_0031427 | |
| Disease | Deaf Mutism | 5.59e-03 | 20 | 166 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 5.59e-03 | 20 | 166 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 5.59e-03 | 20 | 166 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 5.59e-03 | 20 | 166 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 5.59e-03 | 20 | 166 | 2 | C3665473 | |
| Disease | Familial aplasia of the vermis | 5.59e-03 | 20 | 166 | 2 | cv:C0431399 | |
| Disease | Prelingual Deafness | 5.59e-03 | 20 | 166 | 2 | C0011052 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAEEQQKAPGEVMDP | 376 | Q8TAA9 | |
| KPKNNEEIGMLLENN | 1246 | Q96QE3 | |
| MSQKQEEENPAEETG | 1 | O43768 | |
| QENGLEEVKPLGEMQ | 1101 | A6H8Y1 | |
| SGPGEELKINQEMQN | 326 | Q8IWZ6 | |
| EAMKAEAGPVEQQLL | 1981 | Q99996 | |
| GQNPTEAELQDMINE | 41 | P0DP25 | |
| DPSMGLNEEQKEFQK | 36 | Q9UKU7 | |
| ELQKELQEQMSRGDP | 256 | Q7L1Q6 | |
| QEGSMKQEAEQIQPE | 1471 | Q86TB3 | |
| DGMERPGNLNKVVEQ | 126 | Q6ULP2 | |
| LGEEQMIEQVNDEKG | 256 | Q12774 | |
| QPGEVNEDISQELMD | 316 | Q8NFD2 | |
| QNMEQKGKPTGEVEE | 296 | Q96G28 | |
| KGEEPRGDEQQVESM | 476 | Q7Z2Z2 | |
| KASDNEPGIEMQVEN | 426 | P28335 | |
| LGEEQMIEQVNDEKG | 256 | A5YM69 | |
| ISLNKEEMEFQPNQE | 366 | O76090 | |
| PEDDGLEQDLQQVMV | 26 | P53365 | |
| NAEDDKTENQIPQRM | 1721 | Q6UB98 | |
| MKEDQVVAEEPGFQD | 1 | Q14565 | |
| LMNAGEPLNEVEAEQ | 136 | Q8TD86 | |
| GQNPTEAELQDMINE | 41 | P0DP24 | |
| EVLQMEPDNVNALKD | 331 | Q13217 | |
| SEEEMGGNNKIVQDP | 31 | Q5W186 | |
| GPQEINKEELEGNSM | 381 | Q96IK5 | |
| NKKNAAVMDQEPAGD | 366 | P43630 | |
| NKKNAAVMDQEPAGD | 266 | Q8N109 | |
| NNDVKQPEGTGMIDE | 571 | P33176 | |
| LPNEQDLVREEAQKM | 951 | O60271 | |
| NLGNNLLEEVPEEMK | 66 | Q6ZNQ3 | |
| NKEIQDAIAMEGAIP | 896 | Q7Z5J8 | |
| NDNIPVVENKVLEGM | 266 | Q14126 | |
| QNIEENMNIAIEEAP | 221 | Q8WTU0 | |
| LQVPVNENDMKVDEV | 181 | P49914 | |
| DQEPTLGQLEQMLEN | 881 | Q8IY17 | |
| DKKNAAVMDQEPAGN | 271 | P43632 | |
| EKPEDAQQGQQAMSL | 276 | P16389 | |
| IVEVEQDNKMTPGNL | 916 | Q92619 | |
| GKGENEDEKLNEVMQ | 406 | Q8IW41 | |
| KMQVDQEEPHVEEQQ | 521 | P34932 | |
| IQNAKEMENAAIDPE | 301 | Q6NUN7 | |
| LEEVMPQAENQDPDI | 91 | P22301 | |
| IAEEKLSPEQEGQLM | 301 | Q8N201 | |
| NIEKMLGEALGNPQE | 321 | Q9NWT6 | |
| AAVKNTQPEDGVEMD | 331 | Q8NHJ6 | |
| EMAPLQEELSGKGQE | 451 | Q9BQS8 | |
| DQAAGMKEDQKQNEP | 306 | O00180 | |
| VTEKVNLQNNPGAME | 76 | P51572 | |
| EADMQQKKEPVQDDS | 36 | O14576 | |
| QDMGEEAEEEPQKVN | 836 | O43491 | |
| NGNVVKTDVPDMVVE | 331 | P58166 | |
| NKKNAAVMDQEPAGD | 266 | Q8NHK3 | |
| QGDVMVFVEDPEGNK | 286 | O75369 | |
| MDVENEQILNVNPAD | 1 | Q53EL6 | |
| NPDGDDDQLIQITMK | 71 | P55157 | |
| VAEDQEEKQPQLIVM | 221 | Q08174 | |
| LDQQEKMQELGVDPF | 151 | P23409 | |
| QVAPVDLDGMQQDIE | 171 | Q16236 | |
| ENQEAPEVGLDNKMK | 246 | A6NFA0 | |
| GPEDALQKLFEMDAQ | 46 | Q8TE67 | |
| NGNAVQLKEEEEPMD | 6 | O43390 | |
| NSDEMFQKEQVDPLQ | 1401 | O94854 | |
| GPAAGLEMLEEKQQV | 56 | Q6P597 | |
| QEKDNNVLVMDLLGP | 81 | Q8N752 | |
| KAKMDAEQDPNVQVD | 116 | Q02818 | |
| TNMEFKDVIVPENGE | 436 | Q6XUX3 | |
| MEIPEKSVDNQVLEN | 231 | Q8IVE3 | |
| DGEPEPMQKLQDLVN | 236 | Q15291 | |
| PKQGHLQENEIECMV | 71 | P50876 | |
| IMQENENPNGDDISR | 161 | Q8N475 | |
| EEGDVMDKTNGLPVQ | 271 | Q14671 | |
| LVMAGNPDQQEDNVD | 596 | O00461 | |
| LKDTENAIENMVGPD | 756 | O60313 | |
| EPVIVNIQVMDANDN | 491 | Q96QU1 | |
| QTVRPDVKNQDDDMD | 646 | Q9Y2I7 | |
| QDNPQDGIMVKLVVN | 1636 | Q13315 | |
| DGQAGNEEMVQIDLP | 21 | O15072 | |
| NQIQMAGDDVDLPED | 91 | Q7Z7G2 | |
| QDPEKTIGDMFQNQD | 541 | Q96AY3 | |
| NVGESMQLEVEFEPQ | 251 | Q4G0P3 | |
| MEEVGEVENNPVSKA | 2001 | Q4G0P3 | |
| NGQAVPKEKDEMVEQ | 366 | O60341 | |
| VAGQQKPQEQIQAMD | 356 | Q53T59 | |
| MASKEQQIQRDDPGA | 576 | Q9BWV1 | |
| NNMVTTEKVENGQEP | 401 | P55265 | |
| NIAENIEQDFPKPEM | 2716 | Q9H799 | |
| NEEDDPIMVAVNAKV | 296 | O15078 | |
| NMAQIQQGGPDEKEK | 16 | Q8WUF8 | |
| MEAEEENQINEKQEP | 106 | A8MZ97 | |
| TAMKLANQDEGPEDE | 431 | Q6P1N0 | |
| GQKPNIDVTDAMVDQ | 286 | Q9BYF1 | |
| EEREGNMKSAKPQVN | 76 | Q6IMN6 | |
| IMQPTQAVQEGEKSD | 236 | A0A1W2PPF3 | |
| QAQAEDMNVKLEGEP | 581 | Q6PJG2 | |
| GQNPTEAELQDMINE | 41 | P0DP23 | |
| EPGDMLLQVNDVNFE | 296 | O14640 | |
| KNEDFLQLPQDMVVQ | 181 | O14682 | |
| MGPLEAEELQKANET | 1531 | Q8NDH2 | |
| DMLKLAVGDQGPQEE | 16 | Q9H069 | |
| EPGDMLLQVNDVNFE | 296 | P54792 | |
| PAEMVQCLQQKEGEE | 286 | Q6UWW8 | |
| NKDIQEDSGMEPRNE | 291 | O75844 | |
| EVMLQNGETPKDLND | 1671 | Q14839 | |
| MSQVLGKPQPQDEDD | 1 | Q9NQL2 | |
| EVVQQAVKEMNDPSQ | 641 | Q8WUF5 | |
| GMENLLEVQVPEDVE | 346 | Q9BTY7 | |
| MENNADPNIQDKEGR | 476 | Q9Y283 | |
| DKKNAAVMDQEPAGN | 271 | Q14954 | |
| NGPEEKQSVEEMEEQ | 261 | A1Z1Q3 | |
| AQKMEEVAEAAPQEL | 461 | Q8IZ73 | |
| RQQDSEQAVIEKPME | 411 | Q96JX3 | |
| PQLDVTEANKEFMEQ | 246 | Q9NX07 | |
| GPNQVDELKSMEEEL | 656 | Q8IWB6 | |
| MEDVGQNPLDDVKNI | 1 | A8MYB1 | |
| TVQLDENNPVEMKLG | 2596 | P25391 | |
| GPQEINKEDLEGNSM | 381 | Q8NEA9 | |
| NKDEPKSGLNEDQAM | 1911 | Q96Q15 | |
| LQEMNGEPLAAEKEQ | 491 | Q9UK23 | |
| EAIGEMFAEQPKNDL | 451 | Q8WV41 | |
| ELEADMLEQKPQLQV | 36 | Q96LK8 | |
| IAEQMENPDLKNVGS | 591 | Q96EB6 | |
| MMEDGQVQEIDNPEL | 91 | Q8WX94 | |
| QGKMEDLPEQEKNTN | 366 | Q8TF30 | |
| MEGQQPVFEQLEEKL | 126 | Q8WU76 | |
| DQLGLEQDFEQKQMP | 136 | Q13017 | |
| EQDFEQKQMPEGKLN | 141 | Q13017 | |
| PEEQMGQLKYLEQQE | 276 | P07476 | |
| NQEQMKPLEEKQEEE | 81 | P62191 | |
| PEQHVEVDKAVAQNM | 861 | P98171 | |
| KTGEPQSDQQMRQEE | 511 | Q96FL8 | |
| MEEQLNKIPGFCENE | 61 | Q9NRX5 | |
| PQMLQGLLGSDDEEQ | 41 | Q9UPE1 | |
| QAVEMKVQVTEPEGQ | 361 | Q0P6D6 | |
| QQKEEEEEMAVVPQG | 301 | P10645 | |
| NDGNLKVIFPDAEME | 541 | Q96SZ6 | |
| SLIQDGNPMENLEKQ | 6 | Q969Q1 | |
| NNHAKPMEIDGEVEI | 206 | O60907 | |
| DVNLPQDLGDVMKRN | 241 | I1YAP6 | |
| QLFVAQVQMVKDDDP | 316 | Q8NHH1 | |
| MEQEPQNGEPAEIKI | 1 | Q8N0X7 | |
| QLDNEVPEKVAGMEP | 26 | Q86UP3 | |
| GMTPEQQAAIRKEQE | 276 | Q8N443 | |
| NDLNMKAVEQDEPIP | 1741 | Q6GYQ0 | |
| METDNFKLPNDDLQG | 271 | P51512 | |
| PLDKEGNSMEVQVDI | 606 | Q9NV58 | |
| EQGLDPIDGAMNIEK | 521 | Q9NUL3 | |
| MAQDQGEKENPMREL | 1 | P62913 | |
| QQDNGDKVMSKVVPD | 101 | P49675 | |
| GEGDKNVANINEEME | 976 | Q7Z4S6 | |
| MEAPKGVEINAEAGN | 201 | Q92629 | |
| DQLVPDVNMEENLDP | 326 | Q92519 | |
| GMKEEKNLQEGNEVD | 516 | O75152 | |
| MEKPYNKNEGNLENE | 1 | Q6IPX3 | |
| MVPGEENQLVPKEDV | 1 | Q96K76 | |
| EGQQLMQEKPELAAS | 1366 | Q9H254 | |
| MEDQNIIQAPQKEVG | 811 | Q9Y4E1 | |
| NIDAEGKQLMDEKPQ | 1331 | P11277 | |
| ELEGKAQQPAAELMQ | 241 | Q12899 | |
| EDEELNNPMKVLENR | 126 | Q9BW85 | |
| ATVPDNEDGEAKMNI | 831 | Q9UBS9 | |
| EDGKIQQQVDSPMNL | 46 | Q96AE7 | |
| GVKELESLIMQDDPQ | 206 | P49190 | |
| VLPDQDQSDEAQEKM | 376 | Q8IUF8 | |
| EVDKEQMVPNRQKGS | 456 | Q8IYW5 | |
| MEKPYNKNEGNLENE | 1 | Q969E4 | |
| DPEQMTSINGEKAQE | 116 | Q8IUG5 | |
| VEEMAPLKGVQEQQV | 151 | Q16670 | |
| MEDQNIIQAPQKEVG | 811 | Q641Q2 | |
| MNSDDPVVQQKAVLE | 26 | Q9H892 | |
| ALMGEEGKPEINQQL | 51 | Q96LX8 | |
| APDLLMQIKQEGELQ | 181 | Q6NUN9 | |
| LGEKLSMEPNQEETN | 916 | Q9Y210 | |
| EIQGKMEDLPEQEKN | 91 | Q1A5X7 | |
| MEDLPEQEKNINVVD | 96 | Q1A5X7 | |
| MDGDIIVFQKDDPEN | 761 | Q93009 | |
| QVGPVNENVMEEDLK | 1826 | Q14966 | |
| DQPEMILKEAIENHQ | 376 | Q6NUM6 | |
| SEPNLEIGTNDKMNE | 906 | Q86UW6 | |
| SEGDPNKEEMNRIQK | 366 | Q86TC9 |